Envita Medical Centers

AAIT™ treatment information and consultation

Immunotherapy treatment

Advanced Immunotherapy for Cancer When Standard Treatments Aren't Enough

AAIT is a more advanced form of immunotherapy designed to target your specific cancer using your own immune cells and precision testing.

  • For patients with advanced or stage 3–4 cancer
  • For those seeking options beyond standard immunotherapy
  • Personalized approach based on your biology
Uses your own immune cells
Human-grade peptide training
Cells are prepared over time—not rushed
Cell quality is measured before treatment
Patient story 1 / 2
09:42
Play with sound18 second preview loop

Featured testimonial

A patient story about choosing AAIT™ with more confidence

David C.

A longer patient story that adds emotion, context, and a clearer sense of what the treatment journey felt like from the patient side.

Why AAIT™ feels differentiated

Human-grade peptide training, longer expansion, and measured immune-cell quality.

Measured with flow cytometry

Cell count
Viability
Cytotoxic activity
Sterility

25+

Years treating cancer

Stage 3–4

Complex cancer focus

3-Step

Verified cell process

Free

Initial consultation

What Makes AAIT™ Different

How This Advanced Immunotherapy Approach is Different

Not all immunotherapy is the same. Standard approaches often activate the immune system broadly. AAIT™ is designed to be more targeted, more measurable, and more personalized—helping your immune system better recognize and respond to your specific cancer.

More Personalized

AAIT™ uses your own immune cells, creating an approach tailored to your biology rather than a one-size-fits-all treatment.

More Intentional Process

Cells are trained and expanded over time to help improve readiness before treatment—not rushed or generalized.

Measured Before Delivery

Cell quality is evaluated before treatment to help ensure viability and activity.

Why patients explore immunotherapy

Why Patients Look for Advanced or Alternative Immunotherapy

Many patients begin researching more advanced immunotherapy options when standard treatments no longer feel sufficient.

  • Cancer has not responded to chemotherapy or radiation
  • Immunotherapy has not produced expected results
  • Looking for more personalized cancer treatment options
  • Seeking a more targeted immune-based approach
  • Wanting a clearer understanding of what is being delivered

A more personalized approach

AAIT™ begins with your own immune cells, which is why many patients see it as a more individualized form of immunotherapy.

Built around immune recognition

The goal is not simply to deliver cells, but to help the immune system better recognize and respond with greater specificity.

More measured than generic messaging

Training, expansion, and verification create a more structured process than broad promises about immunotherapy alone.

Designed for patients seeking next-step options

For patients researching immunotherapy, AAIT™ can represent a more forward-looking option when they want something more tailored and better explained.

How AAIT™ Works

How AAIT™ works in simple terms.

01

Collect your cells

Your immune cells are collected under clinical supervision as the foundation for a more individualized approach.

02

Train + expand

Cells are trained using peptides and expanded over time to help improve targeting and response.

03

Verify before treatment

Cell quality is measured before delivery, including viability and activity.

What gets measured

How Do You Know What You're Getting Before Treatment?

The technology matters because it helps answer a simple patient question: how do you know what is being prepared before treatment?

Cell count

Viability

Cytotoxic activity

Sterility

Flow cytometry helps quantify cell quality before delivery, not just describe it.

How AAIT™ compares

How AAIT™ Compares to Standard Immunotherapy Approaches

Many patients don't realize how much immunotherapy approaches can vary until they ask the right questions.

At-a-glance filter

If a provider cannot clearly explain how the cells are trained, grown, and verified, it becomes harder to know what you are really buying.

Envita / AAIT™

Specified before treatment

Human-grade peptide training25+ day expansionCell quality is measured before treatment

Typical provider

Details can vary and may stay broad

  • Training methods may not be clearly defined
  • Expansion timelines may be shorter or unclear
  • Limited measurement before treatment

Cell training

Comparison

Envita / AAIT™

Human-grade peptides are used to educate and prepare immune cells for a more targeted response.

Typical provider

Training method may be described broadly or not specified upfront.

Growth window

Comparison

Envita / AAIT™

Cells are expanded over 25+ days before treatment—giving them time to develop.

Typical provider

Expansion time may be shorter or left unclear.

Quality check

Comparison

Envita / AAIT™

Cell count, viability, and activity are measured before delivery—not just described.

Typical provider

Discussion may focus on cell delivery without the same measurement detail.

What the patient can ask for

Comparison

Envita / AAIT™

Specific process checkpoints that can be discussed and reviewed before treatment.

Typical provider

Answers may stay general, making comparisons harder.

Questions to Ask

Questions Worth Asking Any Immunotherapy Provider

What peptides are used to train the cells?
How long are the cells expanded before treatment?
How many cells are delivered?
How is cell strength or activity measured?

If these answers are unclear, it can be harder to understand what you are receiving.

Patient stories

Real Patients Who Chose Advanced Immunotherapy

Hear from patients who explored more personalized immunotherapy options and chose AAIT™.

Envita Medical Centers

David C.

09:42

A patient story about choosing AAIT™ with more confidence

A longer patient story that adds emotion, context, and a clearer sense of what the treatment journey felt like from the patient side.

Watch this story above

Envita Medical Centers

David L.

05:45

A patient case focused on tongue and throat cancer care

A landscape patient case video that gives visitors a clearer second perspective on how Envita approaches tongue and throat cancer care.

Watch this story above

Common questions

Frequently Asked Questions

Patient fit

Is This the Right Fit?

AAIT™ may be considered for patients who:

  • Have advanced or complex cancer
  • Are exploring options beyond standard treatment
  • Are looking for a personalized immunotherapy approach

Next step

See If You Qualify for Advanced Immunotherapy

Speak with a specialist to review your case and explore whether this approach may be appropriate for you.

Or call us directly: 1-866-434-5571